Pasar al contenido principal

Evaluation of the impact on viral assembly of existing and novel mutations on SARS-CoV-2 N protein

FJC2021-046453-I

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Desarrollar, Atraer y Retener Talento
Subprograma Subprograma Estatal de Formación
Convocatoria Juan de la Cierva Formación
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Functional antibody responses targeting the Spike protein of SARS-CoV-2 Omicron XBB.1.5 in elderly nursing home residents following Wuhan-Hu-1-based mRNA booster vaccination

  • Sánchez-Simarro, Ángela
  • Fernández-Soto, Daniel
  • Grau, Brayan
  • Albert, Eliseo
  • Giménez, Estela
  • Avilés-Alía, Ana Isabel
  • Gozalbo-Rovira, Roberto
  • Rusu, Luciana
  • Olea, Beatriz
  • Geller, Ron
  • Reyburn, H. T.
  • Navarro, David
The immune effector mechanisms involved in protecting against severe COVID-19 infection in elderly nursing home residents following vaccination or natural infection are not well understood. Here, we measured SARS-CoV-2 Spike (S)-directed functional antibody responses, including neutralizing antibodies (NtAb) and antibody Fc-mediated NK cell activity (degranulation and IFNγ production), against the Wuhan-Hu-1, BA.4/5 (for NtAb), and Omicron XBB.1.5 variants in elderly nursing home residents (n = 39; median age, 91 years) before and following a third (pre- and post-3D) and a fourth (pre- and post-4D) mRNA COVID-19 vaccine dose. Both 3D and 4D boosted NtAb levels against both (sub)variants. Likewise, 3D and 4D increased the ability of sera to trigger both LAMP1- and IFNγ-producing NK cells, in particular against XBB.1.5. In contrast to NtAb titres, the frequencies of LAMP1- and IFNγ-producing NK cells activated by antibodies binding to Wuhan-Hu-1 and Omicron XBB.1.5 S were comparable at all testing times. Stronger functional antibody responses were observed in vaccine-experienced participants compared to vaccine-naïve at some testing times. These findings can contribute to identifying a reliable correlate of protection in elderly nursing home residents against severe COVID-19 and inform future vaccine strategies in this population group., Ángela Sánchez-Simarro has a contract funded by the Carlos III Health Institute (PFIS Contract; FI22/00338). Eliseo Albert holds a contract funded by the Carlos III Health Institute (co-financed by the European Regional Development Fund, ERDF/FEDER): Juan Rodés Contract; JR20/00011. Brayan Grau is supported by a Juan de la Cierva postdoctoral fellowship (FJC2021-046453-I). This study was supported by the Instituto de Salud Carlos III, Madrid, Spain (FIS, PI21/00563) granted to David Navarro, by the Spanish National Research Council (CSIC, project numbers 202020E079 and CSIC-COVID19-028), and a grant from the Spanish Ministry of Science and Innovation [(MCIU/AEI/FEDER, EU): PID2020-115506RB-I00 (HTR)]. The CNB also acknowledges financial support from the Spanish State Research Agency, AEI/https://doi.org/10.13039/501100011033, through the “Severo Ochoa” Programme for Centres of Excellence in R&D (SEV-2013-0347, SEV-2017-0712). D. Fernández Soto is a recipient of a fellowship (PRE2018-083200) from the Spanish Ministry of Science and Innovation and is a graduate student in the Molecular Biosciences doctoral program of the Autonomous University of Madrid. This research work was also funded by the European Commission – NextGenerationEU (Regulation EU 2020/2094), through the CSIC's Global Health Platform (PTI Salud Global) to Ron Geller and Hugh Reyburn., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Estimating SARS-CoV-2 omicron XBB.1.5 spike-directed functional antibody levels from an anti-receptor binding domain Wuhan-Hu-1-based commercial immunoassay results

  • Sánchez-Simarro, Ángela
  • Cuevas-Ferrando, Enric
  • Fernández-Soto, Daniel
  • Grau, Brayan
  • Albert, Eliseo
  • Giménez, Estela
  • Avilés-Alía, Ana Isabel
  • Rusu, Luciana
  • Geller, Ron
  • Reyburn, H. T.
  • Navarro, David
We investigated whether antibody concentrations measured in plasma using the Roche Elecsys® Anti-SARS-CoV-2 S assay (targeting the receptor binding domain, RBD) could estimate levels of Wuhan-Hu-1 and Omicron XBB.1.5 spike-directed antibodies with neutralizing ability (NtAb) or those mediating NK-cell activity. We analyzed 135 plasma samples from 39 vaccinated elderly nursing home residents. A strong correlation was found for NtAb against both Wuhan-Hu-1 (Rho = 0.73, p < 0.001) and Omicron XBB.1.5 (sub)variants (Rho = 0.73, p < 0.001). Moderate positive correlations were observed for NK-cell activity, based on lysosome-associated membrane protein 1 (LAMP1)-producing NK cells stimulated with Wuhan-Hu-1 (Rho = 0.43, p < 0.001) and Omicron XBB.1.5 spike proteins (Rho = 0.50, p < 0.001). Similarly, interferon-gamma (IFN-γ)-producing NK-cell frequencies showed moderate correlations (Wuhan-Hu-1: Rho = 0.43, p < 0.001; Omicron XBB.1.5: Rho = 0.50, p < 0.001). Random Forest models accurately predicted NtAb levels against Wuhan-Hu-1 (R2 = 0.72), though models for Omicron XBB.1.5 were less robust. Anti-RBD antibody concentrations of 4.73 and 5.02 log10 BAU/mL predicted high NtAb levels for Wuhan-Hu-1 and Omicron XBB.1.5, respectively. Antibody thresholds for predicting functional NK cell-mediated responses were 4.73 log10 and 4.54 log10 BAU/mL for Wuhan-Hu-1 and Omicron XBB.1.5, respectively. For LAMP1-producing NK cells, the thresholds were 4.94 and 4.75 log10 BAU/mL for Wuhan-Hu-1 and Omicron XBB.1.5, respectively. In summary, total anti-RBD antibody levels measured by the Roche assay may allow inference of NtAb levels and, to a lesser extent, Fc-mediated NK-cell responses against Omicron XBB.1.5., Ángela Sánchez‐Simarro has a contract funded by the Carlos III Health Institute (PFIS Contract; FI22/00338). Eliseo Albert holds a contract funded by the Carlos III Health Institute (co‐financed by the European Regional Development Fund, ERDF/FEDER): Juan Rodés Contract; JR20/00011. Brayan Grau is supported by a Juan de la Cierva postdoctoral fellowship (FJC2021‐046453‐I). This study was supported by the Instituto de Salud Carlos III, Madrid, Spain (FIS, PI21/00563) granted to David Navarro, by the Spanish National Research Council (CSIC, project numbers 202020E079 and CSIC‐COVID19‐028), and a grant from the Spanish Ministry of Science and Innovation [(MCIU/AEI/FEDER, EU): PID2020‐115506RB‐I00 (HTR)]. D. Fernández Soto is a recipient of a fellowship (PRE2018‐083200) from the Spanish Ministry of Science and Innovation and is a graduate student in the Molecular Biosciences doctoral program of the Autonomous University of Madrid. The CNB also acknowledges financial support from the Spanish State Research Agency, AEI/10.13039/501100011033, through the“Severo Ochoa” Programme for Centres of Excellence in R&D (SEV‐2013‐0347, SEV‐2017‐0712). This research work was also funded by the European Commission– NextGenerationEU (Regulation EU 2020/2094), through the CSIC's Global Health Platform (PTI Salud Global) to Ron Geller and Hugh Reyburn. The funders had no role in study design, data collection, and interpretation, or in the decision to submit the work for publication., Peer reviewed